COVAXIN booster dose study shows promising results: Bharat Biotech
The phase 2, double-blind, randomised controlled COVAXIN® trial demonstrated long-term safety with no serious adverse events
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona…
Intravacc will focus on a number of additional and preliminary preclinical exercises and the process development research of the…
COVID-19 and adaptation to mental health services
Summarising how NGOs providing mental health outreach services to marginalised and vulnerable populations in India adapted care…
Sleep disruption can vary depending on the respiratory event type and severity in OSA: Research
A recent study conducted in the Sleep Technology and Analytics Research (STAR) group at the University of Eastern Finland…
Deloitte launches playbook to help district administration combat the surge in COVID-19
The playbook demonstrates how supervised home-based care models can help bring limited healthcare resources together to lower the…
- Advertisement -
Pandemic offers opportunities to scale up interventions for the mental health of frontline workers:…
CorStone in collaboration with SNEHA organised a webinar on ‘Roadmap to Resilience: Prioritising the mental health of frontline…
BioGenex Life Sciences launches TRIPLEX COVID-19 RT-PCR Direct
The RT-PCR kit detects all variants of COVID-19 including Omicron
InnAccel Technologies wins the WBG-CES Global Women’s HealthTech awards at CES 2022
The start-up won award for Fetal Lite, an AI powered fetal monitor which can provide accurate readings with limited…
Radiology & Imaging Conclave 2021 | Embracing The New Normal
Picking up from the previous two editions, the first digital Radiology and Imaging Conclave 2021 stirred up thought-provoking…
New frontiers in radiology and imaging
The third panel discussion at Radiology & Imaging Conclave 2021 was ‘New Frontiers in Radiology and Imaging’. The panelists…